NuVasive, Inc., a leading medical device company headquartered in the United States, specialises in innovative spinal surgery solutions. Founded in 1997, the company has established itself as a pioneer in the minimally invasive spine surgery sector, focusing on enhancing surgical outcomes and patient recovery.
With a strong presence across North America, Europe, and Asia, NuVasive offers a comprehensive range of products and services, including advanced surgical instruments, biologics, and imaging technologies. Their unique approach to spinal surgery, characterised by proprietary technologies such as the XLIF® procedure, sets them apart in the competitive landscape.
Recognised for their commitment to innovation, NuVasive has achieved significant milestones, including numerous patents and awards, solidifying their position as a trusted leader in the spinal device market.
-7 vs industry average
NuVasive, Inc.’s score of 21 is lower than 48% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at NuVasive, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Medical Device Manufacturing has typical carbon intensity
Industry performance
The Medical Device Manufacturing industry has reduced its overall emissions by 32% since 2018
Reported emissions
No reported emissions data is available for NuVasive, Inc. yet.
NuVasive, Inc.'s reported carbon emissions
NuVasive, Inc., headquartered in the US, currently does not report any specific carbon emissions data for the latest year. However, the company has set ambitious climate commitments aimed at significantly reducing its environmental impact. NuVasive aims to reduce its Scope 1 and Scope 2 emissions to near zero by the middle of this decade, with a target timeframe from 2023 to 2025.
This commitment reflects a proactive approach to sustainability, aligning with industry standards for climate action. The reduction targets are part of NuVasive's broader strategy to enhance its environmental, social, and governance (ESG) performance.
It is important to note that NuVasive's emissions data is cascaded from its corporate family relationship, specifically from Globus Medical, Inc., which may influence its overall sustainability reporting and initiatives. As the company progresses towards its net-zero goals, it will be crucial to monitor its emissions reductions and overall impact on climate change.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
NuVasive, Inc.’s Climate Goals (2030 & 2050)
2 goals2025
We aim to reduce our Scope 1 and 2 emissions to near zero by…
We aim to reduce our Scope 1 and 2 emissions to near zero by the middle of this decade.
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 2 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisations
NuVasive, Inc.Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project